20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2712 | Nifekalant hydrochloride | Potassium Channel | |
Nifekalant hydrochloride is an IKr potassium channel blocker with an IC50 of 10 µM. It is a Class III antiarrhythmic compound and can be used in the study of tachyarrhythmias. | |||
T3574 | Sematilide hydrochloride | CK-1752A,CK-1752,Sematilide HCl | Potassium Channel |
Sematilide hydrochloride (CK-1752) is a class III antiarrhythmic. It is a selectively delayed rectifier K+ current (IKr) channel blocker. It inhibits rapidly activating Ik in guinea pig atrial myocytes, resulting in the ... | |||
T73611 | Kallikrein | ||
Kallikrein is capable of forming the kallikrenase kalinin system (KKS) in plasma and tissues, producing bradykinin and kalin peptides , respectively [1] . | |||
T40312 | Plasma kallikrein-IN-1 | ||
Plasma kallikrein-IN-1 is a PKK inhibitor with an IC 50 value of 0.5 nM. | |||
T63796 | Kallikrein-IN-2 | ||
Kallikrein-IN-2 (compound 1) is an inhibitor of the kinin-releasing enzyme Kallikrein. | |||
T72337 | Plasma kallikrein-IN-2 | ||
Plasma kallikrein-IN-2, a potent inhibitor of plasma kallikrein (PKal) with an inhibitory concentration (IC) 50 value of 0.1 nM, is utilized in research targeting hereditary angioedema, diabetic macular edema, and diabet... | |||
T63579 | Kallikrein-IN-1 | ||
Kallikrein-IN-1 (Formula A) is an inhibitor of the kinin-releasing enzyme Kallikrein. | |||
T61403 | Plasma kallikrein-IN-3 | ||
Plasma kallikrein-IN-3, a potent inhibitor ( IC 50 : 0.15 μM) of plasma kallikrein, finds application in research related to hereditary angioedema, diabetic macular edema, and diabetic retinopathy [1]. | |||
T72624 | Kallikrein 5-IN-2 | ||
Kallikrein 5-IN-2 is a potent inhibitor of Kallikrein KLK5, exhibiting selectivity with a pIC50 value of 7.1. By inhibiting KLK5, it has the potential to normalize epidermal shedding, thereby reducing associated inflamma... | |||
T30251 | AZD-1305 | UNII-CZO834LXQM,AZD 1305 | Others |
AZD-1305 is a novel anti-arrhythmic compound that primarily blocks the fast component of IKr, l-type calcium currents and intra-ward sodium currents in mammalian cells and ventricular cardiomyocytes and can be used in st... | |||
T23536 | Xamoterol hemifumarate | ICI 118587 hemifumarate,Corwin hemifumarate | Adrenergic Receptor |
Xamoterol hemifumarate is a potent and selective β1-adrenoceptor agonist.Xamoterol hemifumarate is a potential compound for the study of the relationship between cardiac arrhythmias and β1-adrenergic stimulation with IKr... | |||
T7505 | Azimilide Dihydrochloride | NE-10064 Dihydrochloride | Potassium Channel |
Azimilide Dihydrochloride (NE-10064 Dihydrochloride), a novel class III antiarrhythmic agent, blocks both the slowly activating (IKs) and rapidly activating (IKr) components of the delayed rectifier potassium current | |||
T16347 | NS3623 | Potassium Channel | |
NS3623 is an activator of human ether-a-go-go-related gene potassium channels. NS3623 has a dual mode of action, being an inhibitor of hERG1 channels. NS3623 activates the IKr and Ito currents and has an antiarrhythmic e... | |||
T6476 | Dofetilide | UK 68789,UK-68798,Tikosyn | Potassium Channel |
Dofetilide (UK 68789) is a sulfonamide class III antiarrhythmic agent and potassium channel blocker. Dofetilide selectively blocks cardiac ion channels of the rapid component of the delayed rectifier potassium current Ik... | |||
T6633 | Ranolazine | CVT 303,Ranexa,RS 43285-003 | Calcium Channel , Sodium Channel |
Ranolazine (RS 43285-003) is a calcium uptake inhibitor via the sodium/calcium channel, used to treat chronic angina. It affects the sodium-dependent calcium channels during myocardial ischemia in rabbits by altering the... | |||
T0207 | Ranolazine dihydrochloride | RS 43285,Ranolazine 2HCl | Calcium Channel , Sodium Channel , Autophagy |
Ranolazine dihydrochloride (Ranolazine 2HCl) , an antianginal agent, can treat arrhythmia via a novel mechanism of action (inhibition of the late phase of the inward sodium current), and do not affect blood pressure or h... | |||
TP1858L | Phe-Met-Arg-Phe, amide acetate | Phe-Met-Arg-Phe, amide acetate(64190-70-1 freebase) | Potassium Channel |
Phe-Met-Arg-Phe, amide acetate dose dependently (ED50=23 nM) activates a K+ current in the peptidergic caudodorsal neurons. This peptide appears to localize with neuropeptide Y in some regions of the brain. | |||
T12879 | Sematilide | CK-1752 | Others |
Sematilide is a blocker of selective IKr channel. | |||
T14189 | Almokalant | H 234/09 | Potassium Channel |
Almokalant is a class III antiarrhythmic drug, acts as a potassium channel blocker. And it inhibits a specific component (Ikr) of the time-dependent delayed rectifier K+ current. | |||
T72323 | Antiarrhythmic agent-1 | ||
Antiarrhythmic agent-1 (example I), functioning as an antiarrhythmic agent and an IKr potassium channel blocker (IC 50 <1 μM), effectively inhibits cardiac arrhythmias. |